Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

Healthy Adult Male Clinical Trial

Official title:
A Single Center, Open-label, Randomized, 3-arm, 3-way, Crossover Trial to Investigate the Bioequivalence of Brexpiprazole (OPC-34712) Orally Disintegrating Tablets in Healthy Adult Males

Status Completed

Clinical Trial Summary

To investigate the bioequivalence of brexpiprazole ODT 2 mg and brexpiprazole conventional tablet 2 mg

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Adult Male

Clinical Trial Details

NCT number	NCT03902574
Study type	Interventional
Source	Otsuka Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	March 27, 2019
Completion date	June 18, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02875080` - Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects	Phase 1
Completed	`NCT04182958` - A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects	Phase 1
Completed	`NCT05439148` - OPC-61815 in Healthy Chinese Male Subjects	Phase 1
Completed	`NCT02994394` - A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects	Phase 1
Completed	`NCT04415645` - Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects	Phase 1
Completed	`NCT01423435` - Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males	Phase 1
Completed	`NCT01258699` - A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects	Phase 1